La maladie de Parkinson en France (serveur d'exploration) - Curation (Hal)

Index « Auteurs » - entrée « M. Amalric »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
M. Alexander < M. Amalric < M. Amri  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000089 (2012-04) S. Lopez [France] ; L. Jouve [France] ; N. Turle-Lorenzo ; L. Kerkerian-Legoff [France] ; P. Salin [France] ; M. AmalricAntiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity.
000121 (2015-11) N. Maurice [France] ; T. Deltheil ; C. Melon [France] ; B. Degos ; C. Mourre ; M. Amalric ; L. Kerkerian-Le Goff [France]Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease
000329 (2011-08-17) A. Courtiere [France] ; J. Hardouin ; Boris Burle [France] ; F. Vidal [France] ; N. Turle-Lorenzo [France] ; M. Amalric [France] ; T. Hasbroucq [France]Dynamics of Executive Control and Motor Deficits in Parkinsonian Rats
000367 (2005) Freichel C. P. [France] ; Ballard T. M. [France] ; R. Coccurello [France] ; M. Amalric [France] ; Moreau J. L. [France] ; W. Spooren [France]Effects of the A2A receptor antagonist KW-6002 on vigilance and motor performance in aged rats and animal models for early- to late-stage Parkinson's disease.
000460 (2005) N. Turle-Lorenzo [France] ; N. Breysse [France] ; C. Baunez [France] ; M. Amalric [France]Functional interaction between .mGlu5 and NMDA receptors in a rat model of Parkinson's disease.
000461 (2008-09) S. Lopez [France] ; N. Turle-Lorenzo [France] ; Johnston Th [Canada] ; Brotchie Jm [Canada] ; S. Schann [France] ; P. Neuville [France] ; M. Amalric [France]Functional interaction between adenosine A2a and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats
000487 (2013) M. Amalric [France] ; S. Lopez ; C. Goudet [France] ; G. Fisone ; G. Battaglia [France] ; F. Nicoletti ; J. P. Pin ; F. C. AcherGroup III and subtype 4 metabotropic glutamate receptor agonists: Discovery and pathophysiological applications in Parkinson's disease
000570 (2016) S. Ztaou ; N. Maurice [France] ; J. Camon ; G. Guiraudie-Capraz ; L. Kerkerian-Legoff [France] ; C. Beurrier [France] ; M. Liberge ; M. AmalricInvolvement of striatal cholinergic interneurons, M1 and M4 muscarinic receptors in motor symptoms of Parkinson's disease
000652 (2010) B. Greco ; S. Lopez [France] ; H. Putten ; P. J. Flor ; M. Amalric [France]Metabotropic Glutamate 7 Receptor Subtype Modulates Motor Symptoms in Rodent Models of Parkinson's Disease
000653 (2008) De Leonibus E [Italie] ; F. Manag [Italie] ; F. Giordani [Italie] ; F. Petrosino [Italie] ; S. Lopez [France] ; A. Oliverio [Italie] ; M. Amalric [France] ; A. Mele [Italie]Metabotropic Glutamate Receptors 5 Blockade Reverses Spatial Memory Deficits in a Mouse Model of Parkinson's Disease. : in press [full paper]
000656 (2005) M. Amalric [France] ; N. Turle-Lorenzo ; S. LopezMetabotropic glutamate receptors : Potential pharmacological targets in Parkinson's disease treatment
000657 (2008) M. Amalric [France] ; S. Lopez [France]Metabotropic glutamate receptors and Parkinson's disease
000658 (2005) M. Amalric [France]Metabotropic glutamate receptors as potential pharmacological targets in the treatment of Parkinson's disease.
000659 (2005) M. Amalric [France]Metabotropic glutamate receptors: potential pharmacological targets in Parkinson's disease treatment.
000714 (2003) N. Breysse ; M. Amalric [France]NMDA-metabotropic glutamate receptors interaction in a rat model of Parkinson's disease
000948 (2015-10) N. Maurice [France] ; M. Liberge ; F. Jaouen [France] ; S. Ztaou ; M. Hanini [France] ; J. Camon ; K. Deisseroth ; M. Amalric ; L. Kerkerian-Legoff [France] ; C. Beurrier [France]Striatal Cholinergic Interneurons Control Motor Behavior and Basal Ganglia Function in Experimental Parkinsonism
000989 (2014) M. Amalric [France]Targeting Metabotropic Glutamate Receptors (mGluRs) in Parkinson's Disease
000A23 (2006) N. Turle-Lorenzo ; B. Maurin ; C. Puma ; C. Chezaubernard ; P. Morain ; C. Baunez ; A. Nieoullon [France] ; M. AmalricThe dopamine agonist piribédil with L-Dopa improves attentional dysfunction : relevance for Parkinson's disease
000A39 (2007) B. Greco ; S. Lopez [France] ; H. Putten ; P. J. Flor ; M. Amalric [France]The role of metabotropic glutamate receptors 7 in several models of Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Hal/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Hal/Curation/Author.i -k "M. Amalric" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Hal/Curation/Author.i  \
                -Sk "M. Amalric" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Hal/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Hal
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    M. Amalric
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024